Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06192680
What this trial is testing

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Harbin Medical University 63
Not applicableUnknownNCT05233540
What this trial is testing

Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy

Who this might be right for
Anal CancerLocally Advanced Squamous Cell CarcinomaOligometastatic Disease+2 more
Aarhus University Hospital 60
Post-approval studies (Phase 4)Study completedNCT01493713
What this trial is testing

Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer

Who this might be right for
Colorectal CancerHepatic Metastasis
Grupo Espanol Multidisciplinario del Cancer Digestivo 83
Testing effectiveness (Phase 2)Ended earlyNCT00271011
What this trial is testing

Mitomycin C, Irinotecan, and Cetuximab

Who this might be right for
Colorectal Cancer
University of Michigan Rogel Cancer Center 13
Not applicableLooking for participantsNCT06208397
What this trial is testing

MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases

Who this might be right for
Metastatic Colorectal Cancer
Shengjing Hospital 50
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Not applicableStudy completedNCT06048146
What this trial is testing

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

Who this might be right for
Lymph Node MetastasisCancer of Rectum and AnusOxaliplatin+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 180
Testing effectiveness (Phase 2)Study completedNCT01807546
What this trial is testing

Oral Rigosertib for Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more
Traws Pharma, Inc. 64
Not applicableWithdrawnNCT01847495
What this trial is testing

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Testing effectiveness (Phase 2)Ended earlyNCT01523639
What this trial is testing

A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis

Who this might be right for
Colorectal CancerSteatohepatitis
Austrian Breast & Colorectal Cancer Study Group 8
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Testing effectiveness (Phase 2)Looking for participantsNCT05913674
What this trial is testing

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

Who this might be right for
Peritoneal CarcinomatosisAppendiceal NeoplasmsColorectal Cancer Metastatic
Ciusss de L'Est de l'Île de Montréal 25
Not applicableStudy completedNCT02547480
What this trial is testing

LifePearl-Iri Pharmacokinetic Study

Who this might be right for
Metastatic Colorectal CancermCRC
Terumo Europe N.V. 15
Testing effectiveness (Phase 2)Study completedNCT00083720
What this trial is testing

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

Who this might be right for
Colorectal NeoplasmsMetastasesNeoplasm
Eli Lilly and Company 87
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Testing effectiveness (Phase 2)WithdrawnNCT03307603
What this trial is testing

Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT02732860
What this trial is testing

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

Who this might be right for
Colorectal NeoplasmsColorectal CancerBreast Cancer+3 more
University Health Network, Toronto 120
Not applicableUnknownNCT03852290
What this trial is testing

C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon Cancer

Who this might be right for
Colon CancerMTHFR Gene MutationChemotherapeutic Toxicity+1 more
Universidad de Costa Rica 65
Next Page